Name tweak could boost GLP-1 access for one in eight women suffering PMOS

Millions of women could soon have greater access to GLP-1 weight loss medications following the global effort to change the name of a hormonal condition that affects 1 in 8 women globally.

The condition, formerly known as Polycystic Ovarian Syndrome, or PCOS, recently underwent a name change following a years-long international effort, led by the […] ...